Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 2, 2016updated 02 Dec 2021 12:17pm

M&As this week: BioMerieux, Recordati

BioMerieux SA has acquired Hyglos GmbH to further develop its approaches in the detection of endotoxins within pharmaceutical products.

BioMerieux SA has acquired Hyglos GmbH to further develop its approaches in the detection of endotoxins within pharmaceutical products.

The sale consideration of the acquisition is $26.7m, which will be paid in phases over the next three years.

According to the agreement, Hyglos has been merged and consolidated into BioMerieux’s financial statements effective from 1 June 2016.

Recordati S.p.A plans to expand and strengthen its gastroenterology portfolio through its recent acquisition of 100% shares of Italchimici S.p.A.

The purchase consideration of the transaction is $145m, which has been funded from the existing facilities.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU